Provided by Tiger Trade Technology Pte. Ltd.

Haemonetics

105.26
-1.0500-0.99%
Volume:59.55K
Turnover:6.27M
Market Cap:4.78B
PE:51.35
High:106.87
Open:105.11
Low:103.24
Close:106.31
52wk High:109.57
52wk Low:47.32
Shares:45.45M
Float Shares:44.60M
Volume Ratio:0.88
T/O Rate:0.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.05
EPS(LYR):2.05
ROE:11.20%
ROA:6.60%
PB:5.71
PE(LYR):51.35

Loading ...

Haemonetics Signs Non-Exclusive US Plasma Supply Deal with CSL Plasma for NexSys PCS Devices, Disposables

Reuters
·
Aug 18

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17

BofA Securities Adjusts Price Target on Haemonetics to $100 From $93

MT Newswires Live
·
Aug 13

BofA Securities Adjusts Haemonetics Price Target to $100 From $93

MT Newswires Live
·
Aug 12

Press Release: Pharvaris Reports Second Quarter 2026 Financial Results and Provides Business Update

Dow Jones
·
Aug 12

Haemonetics Lifts Outlook on Broad-Based Earnings Strength

TIPRANKS
·
Aug 10

Haemonetics Price Target Raised to $92.00/Share from $79.00 by Citigroup

Dow Jones
·
Aug 08

Barrington Research Adjusts Haemonetics PT to $95 From $89, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

U.S. Research Roundup-Airbnb, Expedia Group, Parker-Hannifin

Reuters
·
Aug 07

Haemonetics Corp : Btig Raises Target Price to $96 from $84

THOMSON REUTERS
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)

TIPRANKS
·
Aug 07

Haemonetics Price Target Raised to $96.00/Share from $84.00 by BTIG

Dow Jones
·
Aug 07

Haemonetics Corp Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Haemonetics' Fiscal Q1 Adjusted Earnings, Net Revenue Increase; Fiscal 2027 Outlook Raised

MT Newswires Live
·
Aug 06

Earnings Flash (HAE) Haemonetics Posts Fiscal Q1 Adjusted EPS $1.14, vs. FactSet Est of $0.87

MT Newswires Live
·
Aug 06

Haemonetics Q1 Adj. EPS $1.14 Beats $1.08 Estimate, Sales $339.380M Beat $327.894M Estimate

Benzinga Earnings
·
Aug 06

Haemonetics Outlook FY Organic Growth 4-7%

THOMSON REUTERS
·
Aug 06

Haemonetics Q1 Adjusted EPS USD 1.14 VS. Ibes Estimate USD 1.08

THOMSON REUTERS
·
Aug 06

Haemonetics FY27 Q1 Adjusted EPS Rises 3.6% to $1.14; Revenue Climbs 5.6% to $339.4 Million

Reuters
·
Aug 06

Haemonetics Corporation Announces First Quarter Fiscal 2027 Financial Results Available on Investor Relations Website

THOMSON REUTERS
·
Aug 06